Cargando…
Complement in Sickle Cell Disease: Are We Ready for Prime Time?
Sickle cell disease (SCD) is a widely spread inherited hemoglobinopathy that includes a group of congenital hemolytic anemias, all characterized by the predominance of sickle hemoglobin (HbS). Its features are anemia, predisposal to bacterial infections and complications such as vaso-occlusive crisi...
Autores principales: | Varelas, Christos, Tampaki, Athina, Sakellari, Ioanna, Anagnostopoulos, Αchilles, Gavriilaki, Eleni, Vlachaki, Efthymia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8001680/ https://www.ncbi.nlm.nih.gov/pubmed/33790681 http://dx.doi.org/10.2147/JBM.S287301 |
Ejemplares similares
-
Immune Response of Adult Sickle Cell Disease Patients after COVID-19 Vaccination: The Experience of a Greek Center
por: Varelas, Christos, et al.
Publicado: (2022) -
PB2226: THE ROLE OF COMPLEMENT IN THE IMMUNE RESPONSE OF SICKLE CELL DISEASE PATIENTS AFER COVID-19 VACCINATION
por: Varelas, C., et al.
Publicado: (2022) -
A New Era in Endothelial Injury Syndromes: Toxicity of CAR-T Cells and the Role of Immunity
por: Gavriilaki, Eleni, et al.
Publicado: (2020) -
Thrombocytopenia in COVID-19: pathophysiology matters
por: Gavriilaki, Eleni, et al.
Publicado: (2020) -
Pre- and Post-transfusion Complement Activation in Transfusion-dependent β-thalassaemia
por: Gavriilaki, Eleni, et al.
Publicado: (2018)